REGENXBIO, Inc. (RGNX)
10.40
+0.08
(+0.73%)
USD |
NASDAQ |
Feb 09, 12:50
REGENXBIO Profit Margin (Quarterly) : -208.3% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Omeros Corp. | -- |
| Sarepta Therapeutics, Inc. | -45.06% |
| AbbVie, Inc. | 10.92% |
| CytomX Therapeutics, Inc. | -238.6% |
| Krystal Biotech, Inc. | 81.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -73.49% |
| Return on Assets | -34.45% |
| Return on Invested Capital | -40.97% |
| Gross Profit Margin (Quarterly) | 67.68% |
| Operating Margin (Quarterly) | -176.3% |
| Return on Net Operating Assets | -89.03% |